REGENERON PHARMACEUTICALS, INC. Public Float
REGENERON PHARMACEUTICALS, INC. (REGN) had Public Float of $54.80 billion as of 2025-06-30, per its 10-K filed 2026-02-04.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-02-04
- 2025-06-30: Entity Public Float $54.80B.
- 2024-06-28: Entity Public Float $113.80B.
- 2023-06-30: Entity Public Float $76.70B.
- 2022-06-30: Entity Public Float $62.00B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $54.80B 10-K · filed 2026-02-04 | |
| 2024-06-28 | $113.80B 10-K · filed 2025-02-05 | |
| 2023-06-30 | $76.70B 10-K · filed 2024-02-05 | |
| 2022-06-30 | $62.00B 10-K · filed 2023-02-06 | |
| 2021-06-30 | $57.06B 10-K · filed 2022-02-07 | |
| 2020-06-30 | $63.34B 10-K · filed 2021-02-08 | |
| 2019-06-28 | $32.93B 10-K · filed 2020-02-07 | |
| 2018-06-29 | $35.74B 10-K · filed 2019-02-07 | |
| 2017-06-30 | $50.34B 10-K · filed 2018-02-08 | |
| 2016-06-30 | $35.22B 10-K · filed 2017-02-09 | |
| 2015-06-30 | $50.63B 10-K · filed 2016-02-11 | |
| 2014-06-30 | $27.32B 10-K · filed 2015-02-12 | |
| 2013-06-28 | $21.19B 10-K · filed 2014-02-13 | |
| 2012-06-30 | $10.36B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $1.73B 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $4.91B 10-Q · filed 2012-10-24 | $1.73B 10-Q · filed 2011-07-28 |
| 2011-03-31 | $1.73B 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $1.73B 10-K · filed 2011-02-17 | |
| 2009-06-30 | $1.36B 10-Q · filed 2010-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |